Review on Allopurinol in the Treatment of Gout
Aryan Aryan,
No information about this author
Vandana Sahani,
No information about this author
Shivanand M. Patil
No information about this author
et al.
Journal for Research in Applied Sciences and Biotechnology,
Journal Year:
2024,
Volume and Issue:
3(6), P. 68 - 74
Published: Dec. 27, 2024
Gout
and
pain
are
synonymous,
a
study
in
this
issue
of
the
BJP
reports
novel
anti-nociceptive
effect
allopurinol,
drug
most
commonly
used
to
treat
gout.
Allopurinol
works
by
inhibiting
xanthine
oxidase
(XO),
enzyme
responsible
for
converting
hypoxanthine
uric
acid
which
is
deposited
as
crystals
joints
gout
sufferers.
Hypoxanthine
metabolite
of,
possible
precursor
to,
adenosine.
find
that
acute
inhibition
XO
with
allopurinol
produces
modest
adenosine
A1
receptor-mediated
common
tests
chemical
thermal
nociception
mice.
A
concomitant
increase
cerebrospinal
fluid
levels
supports
their
hypothesis
increases
via
salvage
from
hypoxanthine.
Elevating
endogenous
metabolism
well-established
strategy
producing
anti-nociception
many
preclinical
models,
but
likely
be
particularly
beneficial
some
chronic
states
because
pro-nociceptive
reactive
oxygen
species
produced
activity.
Thus,
may
have
unexpected
benefits
associated
inflammation,
diabetes
vascular
dysfunction.
Language: Английский
Current Prospective of Hypertension Disease and their Future Aspects in Different Stage of Female Health
Vishal Dixit,
No information about this author
Anamika Anamika,
No information about this author
Shivanand M. Patil
No information about this author
et al.
Journal for Research in Applied Sciences and Biotechnology,
Journal Year:
2024,
Volume and Issue:
3(6), P. 60 - 67
Published: Dec. 27, 2024
Cardiovascular
disease
is
the
primary
cause
of
mortality
in
women.
Due
to
age
and
worsening
risk
factors
over
menopausal
transition,
coronary
heart
events
increases
postmenopausal
women
with
diabetes.
Randomized
studies
have
conflicted
regarding
beneficial
impact
estrogen
therapy
upon
intermediate
cardiovascular
markers
events.
Therefore,
not
currently
recommended
for
indications
other
than
symptom
management.
However,
at
low
adverse
events,
can
be
used
minimize
symptoms.
The
estimated
using
engines
calculation
breast
cancer
conjunction
screening
tools
such
as
mammography.
Use
therapy,
statins,
anti-platelet
agents
guided
by
calculators
particularly
younger
Risk
management
remains
focused
lifestyle
behaviors
achieving
optimal
levels
factors,
including
lipids,
glucose,
blood
pressure.
pharmacologic
therapies
address
these
specific
hypoglycemic
agents,
may
provide
some
additional
benefit
prevention.
minimal
limited
life
expectancy
complications
intensive
should
also
considered.
Language: Английский